Top Markets
Coin of the day
Kailera Therapeutics, Inc. Kailera Therapeutics, Inc.

Kailera Therapeutics, Inc.

KLRA
株式のランク #5958
Kailera Therapeutics is a biopharmaceutical company currently advancing through... Kailera Therapeutics is a biopharmaceutical company currently advancing through its clinical development stage, dedicated to cultivating a varied portfolio of cutting-edge treatments. These therapeutics are specifically engineered to tackle obesity and its associated metabolic disorders. The company distinguishes itself through its focus on innovative methodologies, offering both injectable and orally administered formulations for sustainable weight management. Its most advanced candidate is a groundbreaking dual-action gut hormone receptor agonist, which has reported encouraging outcomes in its initial clinical investigations.
株価
$18.55
時価総額
$2.40B
変化(1日)
0.60%
変化(1年)
-
US
取引 Kailera Therapeutics, Inc. (KLRA)

カテゴリー

Kailera Therapeutics, Inc.(KLRA)の株式分割履歴
Kailera Therapeutics, Inc.株(シンボル:KLRA)は合計で0回の株式分割を実施しました。
最新の株式分割はAug 27, 2026に行われました。
Aug 27, 2026より前に購入されたKLRA株は、現在0KLRA株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH